2 April 2025
This announcement contains inside information
Empyrean Energy PLC / Index: AIM / Epic: EME / Sector: Oil & Gas
Empyrean Energy PLC ('Empyrean' or 'the Company')
DST to be conducted over potential oil zone in the Wilson River-1 well
Empyrean Energy plc ("Empyrean" or the "Company"), the oil and gas development company with interests in Australia, Indonesia and the United States, is pleased to announce the following update on the Wilson River-1 well:
The JV partners in The Wilson River-1 have decided to conduct a Drill Stem Test ("DST") over the potential oil zone identified from analysis of logs and hydrocarbon shows from the well. The JV is currently refining the testing and completion options and getting quotes to carry out the work.
The testing program is currently on schedule to commence during late April. Following the results of the testing program the JV will consider an extended production test.
Other potential zones of interest are still having petrophysical analysis completed along with comparison to producing wells in the region where data is available.
Empyrean CEO, Tom Kelly, stated: "Whilst the testing program is being refined, we are pleased to say that the main potential oil zone will be tested by DST as soon as is practicable. We look forward to providing shareholders with further updates as our plans progress".
The information contained in this announcement has been reviewed by Empyrean's Technical director, Gaz Bisht, who has over 35 years' experience as a hydrocarbon geologist and geoscientist.
For further information please visit www.empyreanenergy.com or contact the following:
| Empyrean Energy plc | Tel: +61 (8) 6146 5325 |
| Tom Kelly | |
| | |
| Cavendish Capital Markets Limited (Nominated Advisor and Broker) | Tel: +44 (0) 207 220 0500 |
| Neil McDonald Pearl Kellie | |
| | |
| Novum Securities Limited (Joint Broker) | Tel: +44 (0) 207 399 9400 |
| Colin Rowbury | |
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.